CHAO VANG: Open Payments
NPI 1578568069 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 36 payments from 12 companies in 2025. Trend: 2023 $1,833 · 2024 $829 · 2025 $881
Food & beverage: $583Education: $298
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 6 | $360 |
| Janssen Biotech, Inc. | 13 | $169 |
| ABBVIE INC. | 4 | $86 |
| Antares Pharma, Inc. | 3 | $72 |
| Endo USA, Inc. | 2 | $40 |
| C. R. Bard, Inc. & Subsidiaries | 1 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Davol Inc. | 1 | $16 |
Products named: ERLEADA, BOTOX, XYOSTED, Xtandi, XIAFLEX, Bard Urinary Drainage Bag, ORGOVYX, Nubeqa.
Industry payments across CA — which companies pay providers there.
